|
🐬
|
Optimizing oncolytic virotherapy in cancer treatment
K. Harrington,
Daniel J. Freeman,
B. Kelly,
J. Harper,
J. Soria
|
8 |
2019 |
8
🐬
|
|
🐜
|
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
24 auth.
Suzanne Mosely,
J. Prime,
R. Sainson,
J. Koopmann,
Dennis Wang,
D. Greenawalt,
M. Ahdesmaki,
R. Leyland,
Stefanie R. Mullins,
Luciano Pacelli,
...
D. Marcus,
J. Anderton,
A. Watkins,
Jane Coates Ulrichsen,
P. Brohawn,
B. Higgs,
M. Mccourt,
Hazel Jones,
J. Harper,
Michelle Morrow,
V. Valge-Archer,
R. Stewart,
S. Dovedi,
R. Wilkinson
|
8 |
2016 |
8
🐜
|
|
🦁
|
Regulation of the anti-tumour immune response by cancer-associated fibroblasts.
J. Harper,
R. Sainson
|
7 |
2014 |
7
🦁
|
|
🐜
|
Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade
8 auth.
Liam Jenkins,
U. Jungwirth,
Alexandra Avgustinova,
M. Iravani,
A. Mills,
S. Haider,
...
J. Harper,
C. Isacke
|
6 |
2022 |
6
🐜
|
|
🐜
|
Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model
11 auth.
Nadia Luheshi,
Jane Coates-Ulrichsen,
J. Harper,
Stefanie R. Mullins,
M. Sulikowski,
Philip Martin,
...
L. Brown,
A. Lewis,
G. Davies,
Michelle Morrow,
R. Wilkinson
|
6 |
2016 |
6
🐜
|
|
🐜
|
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage–response inhibition and immune checkpoint blockade
21 auth.
Emmanuel C Patin,
M. Dillon,
P. Nenclares,
L. Grove,
H. Soliman,
I. Leslie,
Davina Northcote,
G. Bozhanova,
E. Crespo-Rodriguez,
H. Baldock,
...
H. Whittock,
Gabriella Baker,
J. Kyula,
J. Guevara,
A. Melcher,
J. Harper,
H. Ghadially,
Simon A Smith,
M. Pedersen,
M. McLaughlin,
K. Harrington
|
5 |
2022 |
5
🐜
|
|
🐜
|
Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy
8 auth.
Xing Cheng,
Weijia Wang,
Qi Xu,
J. Harper,
Danielle Carroll,
M. Galinski,
...
J. Suzich,
Hong Jin
|
5 |
2016 |
5
🐜
|
|
🐜
|
Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
9 auth.
Shannon Burke,
Amy Shergold,
Matthew J. Elder,
Justine Whitworth,
Xing Cheng,
Hong Jin,
...
R. Wilkinson,
J. Harper,
Danielle Carroll
|
5 |
2020 |
5
🐜
|
|
🐜
|
Evaluation of Newcastle disease virus mediated dendritic cell activation and cross‐priming tumor‐specific immune responses ex vivo
7 auth.
Qi Xu,
Udaya S Rangaswamy,
Weijia Wang,
Scott H. Robbins,
J. Harper,
Hong Jin,
...
Xing-wang Cheng
|
3 |
2019 |
3
🐜
|
|
🦁
|
Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity
19 auth.
J. Harper,
Shannon Burke,
Jon Travers,
N. Rath,
Andrew Leinster,
C. Navarro,
R. Franks,
R. Leyland,
Kathy Mulgrew,
K. McGlinchey,
...
L. Brown,
S. Dovedi,
J. Koopmann,
N. Durham,
Xing Cheng,
Hong Jin,
J. Eyles,
R. Wilkinson,
Danielle Carroll
|
3 |
2021 |
3
🦁
|
